Investment will be used to advance its novel vapor-based ablation system to treat precancerous conditions and metabolic disease such as type 2 diabetes in the gastrointestinal (GI) tract.
Read MoreRadonAway and AccuStar Labs participated in the AARST Radon Symposium in Columbus, OH, sponsoring CE courses, exhibiting products, and supporting initiatives for RRNC and increased public awareness. AccuStar's Carolyn Allen is AARST's new President.
Read More